Matthieu Gregoire

20PUBLICATIONS
33CO-AUTHORS
PharmacogenomicsGene and molecular therapyOrganic green chemistryMedical biochemistry - proteins and peptides (incl. medical proteomics)Glycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jun 27, 2026
Population pharmacokinetics of dalbavancin: external validation, model averaging, and implications for precision dosing in prolonged therapy.

|May 22, 2026
External Evaluation of Population Pharmacokinetic Models of Cabotegravir, During Its Oral and Intramuscular Administration in HIV-Infected Patients.

|Oct 17, 2025
Efficacy, safety, and population pharmacokinetics of a single 1500mg dose of dalbavancin for short-term therapy in patients with chronic prosthetic joint infections.

Eva Benavent, Jaime Lora-Tamayo, Marta Ulldemolins

|Aug 18, 2025
Therapeutic Drug Monitoring of Long-Acting Cabotegravir and Rilpivirine in a National Cohort of People With HIV-1: First Results From the ANRS-MIE CARLAPOP Study.

Nadège Néant, Minh P Lê, Stéphane Bouchet

|Aug 13, 2025
A priori optimization of levofloxacin dose regimen based on a population pharmacokinetics model.

Emmanuel Enard, Matthieu Grégoire, Éric Dailly

|Aug 21, 2023
Therapeutic drug monitoring and virological response at week 48 in a cohort of HIV-1-infected patients switching to dolutegravir/rilpivirine dual maintenance therapy (ANRS-MIE-BIRIDER study).

Florian Lemaitre, Jennifer Lagoutte-Renosi, Marie-Claude Gagnieu

Pageof 4

Frequent Collaborators

5 joint publications

Ronan Bellouard

4 joint publications

Florian Lemaitre

3 joint publications

Jean-François Huon

3 joint publications

Minh P Lê